
Optimotion Implants designs and manufactures advanced knee replacement systems for active patients.
Optimotion Implants, LLC, founded with a mission to transform lives by optimizing motion, specializes in designing and manufacturing advanced knee replacement systems. Their core product, the OI Blue Total Knee System, caters to younger, active patients aiming for a swift recovery. The system includes both cemented and cementless options, enhanced with porous additive manufacturing technology, providing surgeons with versatile and effective solutions. Optimotion focuses on delivering high-quality medical devices that enable patients to embrace life unrestricted.
Notable figures in the company include experienced medical device professionals and orthopedic surgeons who contribute to the innovative design and functionality of their products. Optimotion Implants has achieved significant milestones in the medical device industry, particularly in the development of their patent-pending surgical instrumentation. Their impact is evident in the improved postoperative outcomes and faster recovery times for patients, positioning them as a key player in the knee replacement market.

Active Implants
activeimplants.com

Iconacy Orthopedic Implants
iconacy.com

Consensus Orthopedics
shalbytech.com

Ideal Implant
idealimplant.com
Innvotec Surgical

RevOrtho
revortho.com

Amplify Surgical

BioPoly
biopolyortho.com

Think Surgical
thinksurgical.com

Miach Orthopaedics
miachortho.com

Moximed
moximed.com

Novum Medical

Articulinx
articulinx.com

Orthopediatrics

Woven Orthopedic Technologies
Companies similar to Optimotion Implants include Active Implants, Iconacy Orthopedic Implants, Consensus Orthopedics and Ideal Implant.
Optimotion Implants was founded in 2016.
Optimotion Implants' headquarters is located in Orlando, FL, US.
Optimotion Implants' most recent funding round was for $2.3M (USD) in November 2022.
As of Nov 30, 2022, Optimotion Implants has raised a total of $2.3M (USD).
Optimotion Implants has 3 employees as of Feb 5, 2024.